Christianson Mark sold $32K of NMTC
Christianson Mark (Market Development Director) sold 10,000 shares of NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) at $3.18 on 2026-06-30.
How this was made
The 30-second read
Why it matters
The newest fact is the reported open-market sale by Mark Christianson (Market Development Director) of 10,000 shares at $3.1773, totaling $31,773, with holdings after the trade of 20,692 shares.
Market read
Traders may monitor for continued insider selling, but the filing alone does not provide a fundamental catalyst.
What to watch
The article does not state total position size change beyond the post-transaction holdings, nor does it provide context such as prior sales cadence or tax-related selling.
Background
This is an SEC Form 4 insider transaction disclosure for NEUROONE MEDICAL TECHNOLOGIES (NMTC).
Ticker impact
NEUROONE MEDICAL TECHNOLOGIES Form 4 shows insider Mark Christianson sold 10,000 shares at $3.1773 on 2026-06-30.
Likely limited near-term impact; any effect should be small and fade unless follow-on selling appears.
The filing is a primary-source Form 4, but it is not tied to earnings, guidance, contracts, or regulatory actions. The disclosed size is moderate and the article provides no additional context on company performance or future plans.
Market effects
No sector-level implications; this is an issuer-specific insider transaction.
None indicated.
None indicated.
Counterpoint
Insider sales can be planned for liquidity or diversification; absence of a 10b5-1 plan does not necessarily imply negative expectations.
Key entities
- issuerNEUROONE MEDICAL TECHNOLOGIES Corp
Subject of the Form 4 insider sale disclosure.
- insiderChristianson Mark
Market Development Director who sold shares.
